Show simple item record

dc.contributor.authorCiardiello, JJen
dc.contributor.authorStewart, HLen
dc.contributor.authorSore, Hannahen
dc.contributor.authorGalloway, Warrenen
dc.contributor.authorSpring, Daviden
dc.date.accessioned2017-02-28T16:13:45Z
dc.date.available2017-02-28T16:13:45Z
dc.date.issued2017-06en
dc.identifier.issn0968-0896
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/262809
dc.description.abstractRecent years have witnessed a global decline in the productivity and advancement of the pharmaceutical industry. A major contributing factor to this is the downturn in drug discovery successes. This can be attributed to the lack of structural (particularly scaffold) diversity and structural complexity exhibited by current small molecule screening collections. Macrocycles have been shown to exhibit a diverse range of biological properties, with over 100 natural product-derived examples currently marketed as FDA-approved drugs. Despite this, synthetic macrocycles are widely considered to be a poorly explored structural class within drug discovery, which can be attributed to their synthetic intractability. Herein we describe a novel complexity-to-diversity strategy for the diversity-oriented synthesis of novel, structurally complex and diverse macrocyclic scaffolds from natural product starting materials. This approach exploits the inherent structural (including functional) and stereochemical complexity of natural products in order to rapidly generate diversity and complexity. Readily-accessible natural product-derived intermediates serve as structural templates which can be divergently functionalized with different building blocks to generate a diverse range of acyclic precursors. Subsequent macrocyclisation then furnishes compounds that are each based around a distinct molecular scaffold. Thus, high levels of library scaffold diversity can be rapidly achieved. In this proof-ofconcept study, the natural product quinine was used as the foundation for library synthesis, and six novel structurally diverse, highly complex and functionalized macrocycles were generated.
dc.description.sponsorshipThe research leading to these results has received funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007- 2013)/ERC grant agreement no [279337/DOS]. In addition, the group research was supported by grants from the Engineering and Physical Sciences Research Council, Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and AstraZeneca.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.publisherElsevier
dc.subjectQuinineen
dc.subjectMacrocyclic Compoundsen
dc.subjectMolecular Structureen
dc.titleA novel complexity-to-diversity strategy for the diversity-oriented synthesis of structurally diverse and complex macrocycles from quinine.en
dc.typeArticle
prism.endingPage2843
prism.publicationDate2017en
prism.publicationNameBioorganic & medicinal chemistryen
prism.startingPage2825
prism.volume25en
dc.identifier.doi10.17863/CAM.8098
dcterms.dateAccepted2017-02-26en
rioxxterms.versionofrecord10.1016/j.bmc.2017.02.060en
rioxxterms.versionAMen
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-06en
dc.contributor.orcidSore, Hannah [0000-0002-6542-0394]
dc.contributor.orcidSpring, David [0000-0001-7355-2824]
dc.identifier.eissn1464-3391
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idRoyal Society (WM150022)
pubs.funder-project-idEPSRC (1502980)
pubs.funder-project-idEPSRC (EP/J016012/1)
pubs.funder-project-idEPSRC (EP/P020291/1)
pubs.funder-project-idEuropean Research Council (279337)
cam.orpheus.successThu Jan 30 10:20:26 GMT 2020 - Embargo updated*
rioxxterms.freetoread.startdate2018-06-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record